Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Long COVID

Sep 23, 2022/Clinical Summary

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. As of July 19, 2022, over 559 million cases of COVID-19 and 6.3 million deaths have been confirmed.

APTA Digital Health Transparency Campaign

APTA is asking digital health providers to make the following commitment: Digital "physical therapy" services are only performed or directed by licensed PTs.

Perceived Stress Scale (PSS)

Jul 25, 2022/Test & Measure

Perceived Stress Scale

Rate Your Plate (RYP)

Sep 7, 2022/Test & Measure

2022 APTA Leadership Congress Keynote by Stephanie Creary

Aug 13, 2022/Video

Stephanie J. Creary, PhD, delivered the 2022 APTA Leadership Congress keynote, titled "Principles of Leadership: Advancing DEI By Building Resilient HOPE."

2022 APTA Honors & Awards Ceremony

Aug 14, 2022/Video

APTA celebrated the 2022 class of award recipients at the APTA Leadership Congress.

Issue Brief: Medicare Part B Payment in 2023

Jul 21, 2022/Issue Brief

This issue brief summarizes how the Medicare Physician Fee Schedule works and provides APTA's analysis of the impact on outpatient physical therapy for 2023.

Payment and Regulatory Update: July 20, 2022

Jul 20, 2022/Members Only

Topics discussed: PHE update, Medicare Physician Fee Schedule, Home Health Rule, Commercial Payer Update.

APTA Academy of Geriatric Physical Therapy: Physical Therapist Management of Patients With Suspected or Confirmed Osteoporosis Clinical Practice Guideline (CPG+)

Apr 1, 2022/CPG

Related Resources The Clinician's Guide to Prevention and Treatment of Osteoporosis (April 2022)     CPG+ Appraisal Rating 4.5 out of 7  How was this rating made? Highlights All recommendations are adapted from the Scottish Intercollegiate Guideline Network (SIGN) titled Management of Osteoporosis and

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1